Cancer Research Cell Death Mechanisms and Cancer Therapy  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 7368, August 1, 2007. doi: 10.1158/0008-5472.CAN-07-0515
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lluis, J. M.
Right arrow Articles by Fernandez-Checa, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lluis, J. M.
Right arrow Articles by Fernandez-Checa, J. C.

Experimental Therapeutics, Molecular Targets, and Chemical Biology

Dual Role of Mitochondrial Reactive Oxygen Species in Hypoxia Signaling: Activation of Nuclear Factor-{kappa}B via c-SRC– and Oxidant-Dependent Cell Death

Josep M. Lluis1, Francesca Buricchi2, Paola Chiarugi2, Albert Morales1 and José C. Fernandez-Checa1

1 Liver Unit, Centro de Investigaciones Biomédicas Esther Koplowitz, Instituto de Malalties Digestives, Hospital Clinic I Provincial and CIBEREHD, Instituto Salud Carlos III, University of Barcelona, IDIBAPS and Department of Cell Death and Proliferation, Instituto Investigaciones Biomédicas, Consejo Superior Investigaciones Científicas, Barcelona, Spain and 2 Department of Biochemical Sciences, Faculty of Medicine and Surgery, University of Florence, Florence, Italy

Requests for reprints: José C. Fernández-Checa, Liver Unit, Institut of Malalties Digestives, Hospital Clinic i Provincial, C/ Villarroel, 170, 08036 Barcelona, Spain. Phone: 34-93-451-5272; Fax: 34-93-451-5272; E-mail: checa229{at}yahoo.com.

Hypoxia is a prominent feature of solid tumor development and is known to stimulate mitochondrial ROS (mROS), which, in turn, can activate hypoxia-inducible transcription factor-1{alpha} and nuclear factor-{kappa}B (NF-{kappa}B). Because NF-{kappa}B plays a central role in carcinogenesis, we examined the mechanism of mROS-mediated NF-{kappa}B activation and the fate of cancer cells during hypoxia after mitochondrial reduced glutathione (mGSH) depletion. Hypoxia generated mROS in hepatoma (HepG2, H35), neuroblastoma (SH-SY5Y), and colon carcinoma (DLD-1) cells, leading to hypoxia-inducible transcription factor-1{alpha}–dependent gene expression and c-Src activation that was prevented in cells expressing a redox-insensitive c-Src mutant (C487A). c-Src stimulation activated NF-{kappa}B without I{kappa}B-{alpha} degradation due to I{kappa}B-{alpha} tyrosine phosphorylation that was inhibited by rotenone/TTFA or c-Src antagonism. The c-Src–NF-{kappa}B signaling contributed to the survival of cells during hypoxia as c-Src inhibition or p65 down-regulation by small interfering RNA–sensitized HepG2 cells to hypoxia-induced cell death. Moreover, selective mGSH depletion resulted in an accelerated and enhanced mROS generation by hypoxia that killed SH-SY5Y and DLD-1 cells without disabling the c-Src–NF-{kappa}B pathway. Thus, although mROS promote cell survival by NF-{kappa}B activation via c-Src, mROS overgeneration may be exploited to sensitize cancer cells to hypoxia. [Cancer Res 2007;67(15):7368–77]




This article has been cited by other articles:


Home page
DevelopmentHome page
N. Gavalda, H. Gutierrez, and A. M. Davies
Developmental switch in NF-{kappa}B signalling required for neurite growth
Development, October 15, 2009; 136(20): 3405 - 3412.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
X. Deng, J. P. Luyendyk, P. E. Ganey, and R. A. Roth
Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal Models
Pharmacol. Rev., September 1, 2009; 61(3): 262 - 282.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Aubert, V. Fauquette, B. Hemon, R. Lepoivre, N. Briez, D. Bernard, I. Van Seuningen, X. Leroy, and M. Perrais
MUC1, a New Hypoxia Inducible Factor Target Gene, Is an Actor in Clear Renal Cell Carcinoma Tumor Progression
Cancer Res., July 15, 2009; 69(14): 5707 - 5715.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Fernandez, L. Llacuna, J. C. Fernandez-Checa, and A. Colell
Mitochondrial Cholesterol Loading Exacerbates Amyloid {beta} Peptide-Induced Inflammation and Neurotoxicity
J. Neurosci., May 20, 2009; 29(20): 6394 - 6405.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Llacuna, M. Mari, J. M. Lluis, C. Garcia-Ruiz, J. C. Fernandez-Checa, and A. Morales
Reactive Oxygen Species Mediate Liver Injury Through Parenchymal Nuclear Factor-{kappa}B Inactivation in Prolonged Ischemia/Reperfusion
Am. J. Pathol., May 1, 2009; 174(5): 1776 - 1785.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.